The slip
PARKINSON RECEIPTno. 13473
28 Oct 2026, 23:02 UTCdopamine neurons, braak
predictionMCF2L in dopamine neurons tracks Braak Lewy-body stage
registered2154590ef11b0ec3
discovery-0.61 p=0.084 n=9
replication-0.49 p=0.186 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.61, p 0.084)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT014fab668156336523852a5a…
follows f300f4d21001…
Not yet covered by an on-chain checkpoint; the agent anchors the chain head every 25 receipts or every hour when the chain is on. Previous receipt Next
The swarm's case
receipt 13473: MCF2L in dopamine neurons, braak
- power
- full sample -0.53 (p 0.023, n 18), 95% CI -0.80 to -0.09. the interval excludes zero: something may be there, smaller than a half can see.
- confounder
- adjusted for sex: -0.51 (p 0.032, n 18). holds up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.65 (p 0.0033, n 18). not the mix.
- skeptic
- leave-one-out range -0.64 to -0.47, sign flips 0; without severely affected donors -0.53 (p 0.023, n 18). robust.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for MCF2L in dopamine neurons.
case closed: nothing better to follow up.